Unraveling 'F' factor: towards a genetic-clinical framework for the musculoskeletal-heart crosstalk in metabolic

Yunqiao Zhou1, Jian Huang1, Xinyi Chen1

  • 1Orthopedics Section 1, Dongzhimen Hospital of Beijing University of Chinese Medicine, No. 5 Haiyuncang Hutong, Dongcheng District, Beijing, 100700, China.

Insights

A new "F" factor links heart and bone aging, improving risk prediction for cardiometabolic multimorbidity. This discovery aids early detection and prevention of age-related diseases.

Area of Science:

  • Gerontology
  • Genetics
  • Cardiology

Background:

  • Cardiometabolic diseases and musculoskeletal degeneration often co-occur, posing challenges to healthy aging.
  • Shared biological mechanisms linking these conditions are not well understood.

Purpose of the Study:

  • To develop an integrative clinical-genetic framework to identify a common frailty factor ('F' factor).
  • To elucidate the 'F' factor's role in systemic vulnerability connecting cardiometabolic multimorbidity (CMM) and musculoskeletal aging.

Main Methods:

  • Utilized the China Health and Retirement Longitudinal Study (CHARLS) cohort.
  • Developed and validated Frailty-Integrated Indices for CMM risk prediction using machine learning.
  • Applied Genomic Structural Equation Modeling (Genomic-SEM) to model a shared latent genetic factor ('F' factor) integrating multiple traits.

Main Results:

  • Frailty-Integrated Indices significantly improved CMM risk prediction (AUC=0.727).
  • Identified a significant shared genetic factor ('F' factor) with novel risk loci, including APOE and SLC22A3.
  • Genes implicated in cellular senescence and cholesterol metabolism, with specific expression in endothelial cells.

Conclusions:

  • Converging evidence supports Musculoskeletal-Heart crosstalk in metabolic aging.
  • The 'F' factor is a genetic correlate of a transdiagnostic state linking genetic predisposition to metabolic dysregulation and functional decline.
  • This research aids multi-level characterization of multimorbidity liability for early risk detection and prevention.
Abstract

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...